Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Byington

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|February 1, 1987
Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferonK L Hartshorn, M W Vogt, T C Chou, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 24, 2004
Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patientsE Velasco, M Soares, R Byington, et al.
Lancet (London, England)|March 8, 1986
Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDSM W Vogt, D J Witt, D E Craven, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1991
Systolic Hypertension in the Elderly Program (SHEP). Part 2: Screening and recruitmentH Petrovitch, R Byington, G Bailey, et al.
Journal of Chronic Diseases|January 1, 1987
Mortality in the beta blocker heart attack trial: circumstances surrounding deathR W Peters, R Byington, D Arensberg, et al.
Annals of Internal Medicine|March 1, 1987
Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndromeM W Vogt, D J Witt, D E Craven, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 31, 2007
Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risksC E Klumb, M K Carriço, L M M de Rezende, et al.
Transfusion|July 1, 1985
Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cellsE G Sandstrom, R T Schooley, D D Ho, et al.
Circulation|October 18, 2000
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling ProjectF M Sacks, A M Tonkin, J Shepherd, et al.
The Journal of Infectious Diseases|March 14, 1998
Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 TeamS A Fiscus, M D Hughes, J L Lathey, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|February 1, 1987
Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferonK L Hartshorn, M W Vogt, T C Chou, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 24, 2004
Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patientsE Velasco, M Soares, R Byington, et al.
Lancet (London, England)|March 8, 1986
Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDSM W Vogt, D J Witt, D E Craven, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1991
Systolic Hypertension in the Elderly Program (SHEP). Part 2: Screening and recruitmentH Petrovitch, R Byington, G Bailey, et al.
Journal of Chronic Diseases|January 1, 1987
Mortality in the beta blocker heart attack trial: circumstances surrounding deathR W Peters, R Byington, D Arensberg, et al.
Annals of Internal Medicine|March 1, 1987
Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndromeM W Vogt, D J Witt, D E Craven, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 31, 2007
Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risksC E Klumb, M K Carriço, L M M de Rezende, et al.
Transfusion|July 1, 1985
Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cellsE G Sandstrom, R T Schooley, D D Ho, et al.
Circulation|October 18, 2000
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling ProjectF M Sacks, A M Tonkin, J Shepherd, et al.
The Journal of Infectious Diseases|March 14, 1998
Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 TeamS A Fiscus, M D Hughes, J L Lathey, et al.
Pageof 4